Meta-Analysis of the Effect of Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide in Central Retinal Vein Occlusion

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 9, 2013, Pages 826-831

  Jin, Zi Ye ^a   Zhu, Dan ^a   Tao, Yong ^b   Wong, Ian Y ^c   Jonas, Jost B ^d  

^a AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL MACULAR THICKNESS; CENTRAL RETINA VEIN OCCLUSION; DIABETIC MACULAR EDEMA; DRUG EFFECT; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA EDEMA; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; RETINAL VEIN OCCLUSION; TIME FACTORS; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 84887099679     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0061     Document Type: Article

References (37)

1. McAllister, I.L. Central retinal vein occlusion: a review. Clin. Exp. Ophthalmol. 40:48-58, 2012.
2. Mohamed, Q., McIntosh, R.L., Saw, S.M., et al. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 114:507-519, 524, 2007. (Pubitemid 46282974)
3. Ehlers, J.P., and Fekrat, S. Retinal vein occlusion: beyond the acute event. Surv. Ophthalmol. 56:281-299, 2011.
4. Jonas, J.B., Kreissig, I., and Degenring, R.F. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch. Clin. Exp Ophthalmol. 240:782-783, 2002. (Pubitemid 36097108)
5. Tao, Y., and Jonas, J.B. Intravitreal triamcinolone. Ophthalmologica. 225:1-20, 2011.
6. Ip, M.S., and Kumar, K.S. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch. Ophthalmol. 120:1217-1219, 2002. (Pubitemid 35034350)
7. Park, C.H., Jaffe, G.J., and Fekrat, S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am. J. Ophthalmol. 136:419-425, 2003. (Pubitemid 37101237)
8. Krepler, K., Ergun, E., Sacu, S., et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol. Scand. 83:71-75, 2005. (Pubitemid 40326425)
9. Tao, Y., Hou, J., Jiang, Y.R., et al. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Eye. 24:810-815, 2010.
10. Rosenfeld, P.J., Fung, A.E., and Puliafito, C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg. Laser Imaging. 36: 336-339, 2005. (Pubitemid 41073113)
11. Lim, J.W., and Na, K.I. A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision. Indian J. Ophthalmol. 59:93-96, 2011.
12. Ding, X., Li, J., Hu, X., et al. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Retina. 31:838-845, 2011.
13. Wang, H.Y., Li, X., Wang, Y.S., et al. Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion. Int. J. Ophthalmol. 4:89-94, 2011.
14. Wu, W.C., Cheng, K.C., and Wu, H.J. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Eye. 23:2215-2222, 2009.
15. Jadad, A.R., Moore, R.A., Carroll, D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control. Clin. Trials. 17:1-12, 1996. (Pubitemid 26120810)
16. Iturralde, D., Spaide, R.F., Meyerle, C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 26:279-284, 2006. (Pubitemid 44318180)
17. Spandau, U.H., Ihloff, A.K., and Jonas, J.B. Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol. Scand. 84:555-556, 2006. (Pubitemid 44109048)
18. Shetty, R., Pai, S.A., Vincent, A., et al. Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema. Doc. Ophthalmol. Adv. Ophthalmol. 116:129-135, 2008. (Pubitemid 351279804)
19. Ferrara, D.C., Koizumi, H., and Spaide, R.F. Early bevacizumab treatment of central retinal vein occlusion. Am. J. Ophthalmol. 144:864-871, 2007. (Pubitemid 350122344)
20. Moschos, M.M., and Moschos, M. Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study. Doc. Ophthalmol. Adv. Ophthalmol. 116:147-152, 2008.
21. Hsu, J., Kaiser, R.S., Sivalingam, A., et al. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina. 27:1013-1019, 2007. (Pubitemid 350304000)
22. Priglinger, S.G., Wolf, A.H., Kreutzer, T.C., et al. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina. 27:1004-1012, 2007. (Pubitemid 350303999)
23. Rensch, F., Jonas, J.B., and Spandau, U.H. Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion. Acta Ophthalmol. 87:77-81, 2009.
24. Bashshur, Z.F., Ma'luf RN, Allam, S., et al. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch. Ophthalmol. 122:1137-1140, 2004. (Pubitemid 39031128)
25. Cekic, O., Chang, S., Tseng, J.J., et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina. 25:846-850, 2005. (Pubitemid 41456574)
26. Degenring, R.F., Kamppeter, B., Kreissig, I., et al. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol. Scand. 81:399-401, 2003. (Pubitemid 36926869)
27. Greenberg, P.B., Martidis, A., Rogers, A.H., et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br. J. Ophthalmol. 86:247-248, 2002. (Pubitemid 34127557)
28. Ip, M., Kahana, A., and Altaweel, M. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin. Ophthalmol. 18:67-73, 2003. (Pubitemid 37108395)
29. Ip, M.S., Gottlieb, J.L., Kahana, A., et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch. Ophthalmol. 122:1131-1136, 2004. (Pubitemid 39031127)
30. Jonas, J.B., Akkoyun, I., Kamppeter, B., et al. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion. Eur. J. Ophthalmol. 15:751-758, 2005. (Pubitemid 43074702)
31. Fung, A.E., Rosenfeld, P.J., and Reichel, E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 90:1344-1349, 2006. (Pubitemid 44702055)
32. Kwon, S.I., Kim, Y.W., Bang, Y.W., et al. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion. J. Ocul. Pharmacol. Ther. 29:5-9, 2013.
33. Ramezani, A., Esfandiari, H., Entezari, M., et al. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion. Graefes Arch. Clin. Exp. Ophthalmol. 250:1149-1160, 2012.
34. Higashiyama, T., Sawada, O., Kakinoki, M., et al. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. Acta Ophthalmol. 91:318-324, 2013.
35. Hou, J., Tao, Y., Jiang, Y.R., et al. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study. Chin. Med. J. 122:2695-2699, 2009.
36. Zhang, Y., Ma, J., Meng, N., et al. Comparison of intravitreal triamcinolone acetonide with intravitreal bevacizumab for treatment of diabetic macular edema: a meta-analysis. Curr. Eye Res. 38: 578-587,2013.
37. Guthoff, R., Meigen, T., Hennemann, K., et al. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to central retinal vein occlusion-a matched-pairs analysis. Ophthalmologica. 224:126-132, 2010.